Delivery Order SPE2DB24D2100-SPE2DB26FBAJR
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s on July 8, 2025. The delivery order, valued at $4,520.16, represents a competitive award with no set-aside designation and an ultimate completion date of July 9, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $7,723.82. This firm fixed-price, non-set-aside contract is part of the company's broader relationship with the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies to support military and federal healthcare systems. The order is scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Lidocaine 5% Patch 30s by the Defense Logistics Agency (DLA) on July 21, 2025. This firm fixed-price, competitively awarded contract has a ceiling value of $1,155.74 and an ultimate completion date of July 22, 2025. The award was not designated as a set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,277.57 by the Defense Logistics Agency for the supply of Lidocaine 5% Patch 30s. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a firm fixed price contract with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $13,932.60 and a firm fixed price structure. The delivery order carries an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s, with a ceiling value of $1,181.76. The award was made on July 21, 2025, as a firm fixed price delivery order with an ultimate completion date of July 22, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs, with performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $5,418.73. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,532.72 by the Defense Logistics Agency (DLA) on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract involves the supply of Lidocaine 5% Patch 30s, a topical anesthetic pharmaceutical product. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. The award...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB26FBAJRDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively-awarded delivery order on October 21, 2025, by the Defense Logistics Agency to supply Lidocaine 5% Patch 30s with a ceiling value of $3,549.60. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 22, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order represents a routine pharmaceutical procurement supporting the Defense Logistics Agency's medical supply chain operations. As a critical vendor for federal medical procurement, AmerisourceBergen supplies medications and medical commodities across multiple therapeutic domains to serve customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular award carries no set-aside designation, indicating it was awarded through open competitive procurement processes consistent with the company's track record of meeting federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 10/21/25 |